These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 27863026)

  • 1. Design and Synthesis of Selurampanel, a Novel Orally Active and Competitive AMPA Receptor Antagonist.
    Orain D; Tasdelen E; Haessig S; Koller M; Picard A; Dubois C; Lingenhoehl K; Desrayaud S; Floersheim P; Carcache D; Urwyler S; Kallen J; Mattes H
    ChemMedChem; 2017 Feb; 12(3):197-201. PubMed ID: 27863026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 6-Amino quinazolinedione sulfonamides as orally active competitive AMPA receptor antagonists.
    Orain D; Ofner S; Koller M; Carcache DA; Froestl W; Allgeier H; Rasetti V; Nozulak J; Mattes H; Soldermann N; Floersheim P; Desrayaud S; Kallen J; Lingenhoehl K; Urwyler S
    Bioorg Med Chem Lett; 2012 Jan; 22(2):996-9. PubMed ID: 22197388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quinazolinedione sulfonamides: a novel class of competitive AMPA receptor antagonists with oral activity.
    Koller M; Lingenhoehl K; Schmutz M; Vranesic IT; Kallen J; Auberson YP; Carcache DA; Mattes H; Ofner S; Orain D; Urwyler S
    Bioorg Med Chem Lett; 2011 Jun; 21(11):3358-61. PubMed ID: 21531559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and Pharmacological Evaluation of 3-[(4-Oxo-4H-pyrido[3,2-e][1,3]thiazin-2-yl)(phenyl)amino]propanenitrile Derivatives as Orally Active AMPA Receptor Antagonists.
    Inami H; Shishikura JI; Yasunaga T; Hirano M; Kimura T; Yamashita H; Ohno K; Sakamoto S
    Chem Pharm Bull (Tokyo); 2019; 67(7):699-706. PubMed ID: 31257325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3,5-Dihydro-4H-2,3-benzodiazepine-4-thiones: a new class of AMPA receptor antagonists.
    Chimirri A; De Sarro G; De Sarro A; Gitto R; Quartarone S; Zappalà M; Constanti A; Libri V
    J Med Chem; 1998 Aug; 41(18):3409-16. PubMed ID: 9719593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, structure-activity relationships, and anticonvulsant activities of 2-amino-4H-pyrido[3,2-e][1,3]thiazin-4-one derivatives as orally active AMPA receptor antagonists.
    Inami H; Shishikura J; Yasunaga T; Ohno K; Yamashita H; Kato K; Sakamoto S
    Bioorg Med Chem; 2015 Apr; 23(8):1788-99. PubMed ID: 25792143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SPD 502: a water-soluble and in vivo long-lasting AMPA antagonist with neuroprotective activity.
    Nielsen EO; Varming T; Mathiesen C; Jensen LH; Moller A; Gouliaev AH; Wätjen F; Drejer J
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1492-501. PubMed ID: 10336544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 8-(1H-imidazol-1-yl)-7-nitro-4(5H)-imidazo[1,2-alpha]quinoxalinone and related compounds: synthesis and structure-activity relationships for the AMPA-type non-NMDA receptor.
    Ohmori J; Shimizu-Sasamata M; Okada M; Sakamoto S
    J Med Chem; 1997 Jun; 40(13):2053-63. PubMed ID: 9207947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-activity studies of 6-substituted decahydroisoquinoline-3-carboxylic acid AMPA receptor antagonists. 2. Effects of distal acid bioisosteric substitution, absolute stereochemical preferences, and in vivo activity.
    Ornstein PL; Arnold MB; Allen NK; Bleisch T; Borromeo PS; Lugar CW; Leander JD; Lodge D; Schoepp DD
    J Med Chem; 1996 May; 39(11):2232-44. PubMed ID: 8667366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atropisomeric quinazolin-4-one derivatives are potent noncompetitive alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor antagonists.
    Welch WM; Ewing FE; Huang J; Menniti FS; Pagnozzi MJ; Kelly K; Seymour PA; Guanowsky V; Guhan S; Guinn MR; Critchett D; Lazzaro J; Ganong AH; DeVries KM; Staigers TL; Chenard BL
    Bioorg Med Chem Lett; 2001 Jan; 11(2):177-81. PubMed ID: 11206453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phthalazine-1,4-dione derivatives as non-competitive AMPA receptor antagonists: design, synthesis, anticonvulsant evaluation, ADMET profile and molecular docking.
    El-Helby AA; Ayyad RRA; El-Adl K; Elkady H
    Mol Divers; 2019 May; 23(2):283-298. PubMed ID: 30168051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3-Hydroxy-1H-quinazoline-2,4-dione derivatives as new antagonists at ionotropic glutamate receptors: molecular modeling and pharmacological studies.
    Colotta V; Lenzi O; Catarzi D; Varano F; Squarcialupi L; Costagli C; Galli A; Ghelardini C; Pugliese AM; Maraula G; Coppi E; Pellegrini-Giampietro DE; Pedata F; Sabbadin D; Moro S
    Eur J Med Chem; 2012 Aug; 54():470-82. PubMed ID: 22704999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-activity relationships in a series of 2(1H)-quinolones bearing different acidic function in the 3-position: 6,7-dichloro-2(1H)-oxoquinoline-3-phosphonic acid, a new potent and selective AMPA/kainate antagonist with neuroprotective properties.
    Desos P; Lepagnol JM; Morain P; Lestage P; Cordi AA
    J Med Chem; 1996 Jan; 39(1):197-206. PubMed ID: 8568808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1-Aryl-3,5-dihydro-4H-2,3-benzodiazepin-4-ones: novel AMPA receptor antagonists.
    Chimirri A; De Sarro G; De Sarro A; Gitto R; Grasso S; Quartarone S; Zappalà M; Giusti P; Libri V; Constanti A; Chapman AG
    J Med Chem; 1997 Apr; 40(8):1258-69. PubMed ID: 9111300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heteroaryl analogues of AMPA. Synthesis and quantitative structure-activity relationships.
    Bang-Andersen B; Lenz SM; Skjaerbaek N; Søby KK; Hansen HO; Ebert B; Bøgesø KP; Krogsgaard-Larsen P
    J Med Chem; 1997 Aug; 40(18):2831-42. PubMed ID: 9288165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heteroaryl analogues of AMPA. 2. Synthesis, absolute stereochemistry, photochemistry, and structure-activity relationships.
    Falch E; Brehm L; Mikkelsen I; Johansen TN; Skjaerbaek N; Nielsen B; Stensbøl TB; Ebert B; Krogsgaard-Larsen P
    J Med Chem; 1998 Jul; 41(14):2513-23. PubMed ID: 9651156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel AMPA receptor antagonists: synthesis and structure-activity relationships of 1-hydroxy-7-(1H-imidazol-1-yl)-6-nitro-2,3(1H,4H)- quinoxalinedione and related compounds.
    Ohmori J; Shimizu-Sasamata M; Okada M; Sakamoto S
    J Med Chem; 1996 Sep; 39(20):3971-9. PubMed ID: 8831762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of 2-[N-(4-chlorophenyl)-N-methylamino]-4H-pyrido[3.2-e]-1,3-thiazin-4-one (YM928), an orally active alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antagonist, in models of generalized epileptic seizure in mice and rats.
    Yamashita H; Ohno K; Amada Y; Hattori H; Ozawa-Funatsu Y; Toya T; Inami H; Shishikura J; Sakamoto S; Okada M; Yamaguchi T
    J Pharmacol Exp Ther; 2004 Jan; 308(1):127-33. PubMed ID: 14569061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BGG492 (selurampanel), an AMPA/kainate receptor antagonist drug for epilepsy.
    Faught E
    Expert Opin Investig Drugs; 2014 Jan; 23(1):107-13. PubMed ID: 24147649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and development of 2,3-benzodiazepine (CFM) noncompetitive AMPA receptor antagonists.
    Gitto R; Zappal M; De SG; Chimirri A
    Farmaco; 2002 Feb; 57(2):129-34. PubMed ID: 11902655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.